PHARMIS
Meeting Presentation. January 2026. Strictly confidential. 

Scene 1

Our Vision Targeted of Higl»QLnlity Strategic Selection of partners. 

Scene 2

Our Vision
Targeted
of Higl»QLnlity
Strategic Selection of
partners

PHARMIS is a Moroccan pharmaceutical company established with the strategic objective of supporting the sustainable development of the national pharmaceutical market and contributing to the continuous improvement of population access to high-quality healthcare. Driven by a strong commitment to public health and regulatory excellence, PHARMIS operates at the intersection of innovation, industrial performance, and affordability. The company’s mission is to deliver safe, effective, and accessible pharmaceutical solutions aligned with international standards, while responding to the specific needs of the Moroccan healthcare ecosystem. Through a long-term vision focused on market structuring, local value creation, and partnership with key stakeholders, PHARMIS aims to play a pivotal role in strengthening pharmaceutical sovereignty and enhancing healthcare outcomes across Morocco.

PHARMIS aims to build a patient-centric pharmaceutical platform through disciplined product selection and strategic partnerships, driving sustainable growth and long-term value creation.

PHARMIS’s goal is to create lasting value for patients and healthcare professionals by ensuring consistent access to high-quality pharmaceutical products that strengthen healthcare outcomes and system sustainability.

PHARMIS’s mission is to deliver high-quality, safe, and effective pharmaceutical products while ensuring affordability and accessibility, in support of patients, healthcare professionals, and healthcare systems.

Company overview. Confidential - 3. Legal Form & Capital. 

Scene 3

Importation, manufacturing, marketing, promotion and distribution of pharmaceutical products, medical devices and complements foods, for its own account or under license of foreign laboratories.

Limited Corporation with a capital of 90 Millions Dirhams   (9 Millions USD)

March 2010. October 2010. May 2011. Chronology of Creation. 

Scene 4

Establishment of PHARMIS LLC,  with a capital of 2 Millions DH

MOH Authorization as Industrial Pharmaceutical establishment (GMP)

Capital increased to reach 30 Millions DH

Location. Confidential - 5. Tangier Fes Rabat Casablanca Beni Mellal Agadir. 

Scene 5

Tangier
 Fes
 Rabat Casablanca


 Beni Mellal Agadir

Zone industrielle Ouest Ain Harrouda, Route régionale N° 322 - Km 12.400, Ain Harrouda,  28630 - Mohammedia

organization chart. Confidential - 6. [image] vsM Hatim Erroufus Loutr,a MO'JCHRIT SENsuO'Jl CYEf G SELGHMI. 

Scene 6

[image] vsM
Hatim
Erroufus
Loutr,a MO'JCHRIT
SENsuO'Jl
CYEf G
SELGHMI

Lay Out. Confidential - 7. ATB ADM Magasin Magasin ACCÉSS P NCIP'ÄL Formes ÄCCÉS PRINCIPAL. 

Scene 7

ATB
ADM
Magasin
Magasin
ACCÉSS
P NCIP'ÄL
Formes
ÄCCÉS
PRINCIPAL

PHARMIS owns 4 buildings:  Administrative Unit; Cephalosporin's Unit; Dry Forms Unit; Finished Products Warehouse.

Administrative Building. Confidential - 8. Pharmis Headquarters is located in Ain Sbaa (Casablanca) Administrative offices occupy an area of 1,000 m² and a total height of 20 m spread over 5 floors. The building was built according to latest standards.. 

Scene 8

Pharmis Headquarters is located in Ain Sbaa (Casablanca) Administrative offices occupy an area of 1,000 m² and a total height of 20 m spread over 5 floors.  The building was built according to latest standards.

3rd FLOOR
• Executive Offices
• Lobby
ISt
• Meeting Rooms
Human Resources
2nd FLOOR
open Offices
• IT Department
GROUND FLOOR (G.F.)
• Reception
2nd FLOOR
Open Offices
$4

CEPHALOSPORINS UNIT. Confidential - 9. Production unit dedicated exclusively to oral cephalosporin, rented to SUN PHARMA MOROCCO. A small and functional unit with an area of 1160 m² on 4 levels.. 

Scene 9

Production unit dedicated exclusively to oral cephalosporin, rented to SUN PHARMA MOROCCO.  A small and functional unit with an area of 1160 m² on 4 levels.

Une image contenant ciel, Bâtiment commercial, façade, plein air

Le contenu généré par l’IA peut être incorrect.

GROUND FLOOR (G.F.)
Warehouse
Weighing Center
• Male & Female Locker Rooms
1st FLOOR
• n Manufacturing
Packaging
Packaging II
2nd & 3rd FLOORS
Quality Assurance g Control
FLOOR
2nd FLOOR
Packaging I

Dry Forms Unit. Confidential - 10. The unit of dry forms occupy an area of ​​4800 m² on 5 floors.. 

Scene 10

The unit of dry forms occupy an area of ​​4800 m² on 5 floors.

BUILDING LAYOUT
Facility Floor Overview
Quality Control
Future Expansion
Dry Form
Warehouse, purified
Water Station, Locker Rooms,
& Weighing Station
Technical Zone
GROUND FLOOR
4th FLOOR
3rd FLOOR
Future Expansion
2nd FLOOR
Dry Form
FLOOR
Dry Floor

P.F. Storage Warehouse. Confidential - 11. The new warehouse of finished Product was built with A total area of 3024 m² on 2 levels; A total storage capacity of 4000 pallets. This New store is composed of: An area for storage of thermostable products . PICKING area for delivery orders An area dedicated for export in order to have a better inventory management under Customs.. 

Scene 11

The new warehouse of finished  Product was built  with  A total area of  3024 m² on  2 levels; A total storage capacity of 4000 pallets. This New store is composed of: An area for storage of thermostable products . PICKING area for delivery orders An area dedicated for export in order to have a  better inventory management under Customs.

Human ressources. Confidential - 12. Une image contenant texte, capture d’écran, diagramme, logiciel Le contenu généré par l’IA peut être incorrect.. 

Scene 12

Une image contenant texte, capture d’écran, diagramme, logiciel

Le contenu généré par l’IA peut être incorrect.

Our Partners. Confidential - 13. [image] cid image001 png 01D0665F 4E9F1880. 

Scene 13

[image] cid image001 png 01D0665F 4E9F1880

Chanelle Group rebrands to Chanelle Pharma - Chanelle Pharma

Business Model. Confidential - 14. Our Core Business & Partners: RANBAXY SUN pHARMA BEXIMCO PHARMA Tvo BEXIMCO PHARMA Chanellé PHARMA BEXIMCO PHARMA Regienal kibion BEXIMCO PHARMA $lnmure PHARMIS Products •curing. 

Scene 14

Our Core Business & Partners:
RANBAXY
SUN
pHARMA
BEXIMCO
PHARMA
Tvo
BEXIMCO PHARMA
Chanellé
PHARMA
BEXIMCO
PHARMA
Regienal
kibion
BEXIMCO
PHARMA
$lnmure
PHARMIS
Products
•curing

Products List. Confidential - 15. zuzMA@3 Aciclovir•. 

Scene 15

[image] MOVFOR
Molnuptraw Capsules 200 mg

ErloåReV
ErlotiRel (Erlotinib), a kinase inhibitor,

RelüTreve.W@
Pemetrexed disodium heptahydrate

R eléOo-mLde;
Lenalidomide, a thalidomide analogue,

PHARMIS Sales Performance History. Confidential - 16. 

Scene 16

Sales 2019 2020 2021 2022 202 2024 2025e 50968354 70280556 95667892 115547093 128106945 217014151 251761672

Confidential - 17. Thank you for your attention. '(ØPHfAHMlS. 

PHARMIS Meeting Presentation

Scene 1 (0s)

Scene 2 (7s)

Scene 3 (10s)

Scene 4 (13s)

Scene 5 (32s)

Scene 6 (35s)

Scene 7 (38s)

Scene 8 (41s)

Scene 9 (44s)

Scene 10 (47s)

Scene 11 (50s)

Scene 12 (53s)

Scene 13 (56s)

Scene 14 (59s)

Scene 15 (1m 2s)

Scene 16 (1m 5s)

Scene 17 (1m 7s)